Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for anesthesia in vocal cord polyp resection
ChiCTR2300068097Phase 4Recruiting
- Sponsor
- Xinxiang Central Hospital
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in laryngeal polyp (2 arms), sponsored by Xinxiang Central Hospital. Primary endpoints: Postoperative recovery quality score QoR-15 and Effects on hemodynamics. Started Jan 2023; status: recruiting.
02
Drugs
remimazolam
03
Conditions
laryngeal polyp
Beyond the preview
Go deeper on ChiCTR2300068097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300068097.